$438.10
0.160.04%
At Close: -
$438.10
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Comments
Loading...
Northrop Grumman
NOCNYSE
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Northrop Grumman (NYSE:NOC) Stock, Analyst Ratings, Price Targets, Forecasts
Northrop Grumman Corp has a consensus price target of $492.7 based on the ratings of 23 analysts. The high is $615 issued by B of A Securities on July 28, 2023. The low is $375 issued by Goldman Sachs on January 13, 2023. The 3 most-recent analyst ratings were released by BTIG, Bernstein, and Wells Fargo on June 26, 2024, June 21, 2024, and April 30, 2024, respectively. With an average price target of $520 between BTIG, Bernstein, and Wells Fargo, there's an implied 18.69% upside for Northrop Grumman Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
BTIG
Bernstein
Wells Fargo
RBC Capital
Susquehanna
1calculated from analyst ratings
Analyst Ratings for Northrop Grumman
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/26/2024 | Buy Now | 28.97% | BTIG | Andre Madrid | → $565 | Initiates | → Buy | Get Alert |
| 06/21/2024 | Buy Now | 8.88% | Bernstein | Douglas Harned | → $477 | Downgrade | Outperform → Market Perform | Get Alert |
| 04/30/2024 | Buy Now | 18.24% | Wells Fargo | Matthew Akers | $483 → $518 | Maintains | Equal-Weight | Get Alert |
| 04/26/2024 | Buy Now | 8.42% | RBC Capital | Ken Herbert | $450 → $475 | Maintains | Sector Perform | Get Alert |
| 04/26/2024 | Buy Now | 27.82% | Susquehanna | Charles Minervino | $540 → $560 | Maintains | Positive | Get Alert |
| 04/26/2024 | Buy Now | 15.27% | Baird | Peter Arment | $475 → $505 | Maintains | Neutral | Get Alert |
| 04/22/2024 | Buy Now | — | Alembic Global | Peter Skibitski | — | Upgrade | Neutral → Overweight | Get Alert |
| 01/26/2024 | Buy Now | 23.26% | Susquehanna | Charles Minervino | $560 → $540 | Maintains | Positive | Get Alert |
| 01/26/2024 | Buy Now | 8.42% | Baird | Peter Arment | $505 → $475 | Maintains | Neutral | Get Alert |
| 01/26/2024 | Buy Now | 2.72% | RBC Capital | Ken Herbert | $515 → $450 | Downgrade | Outperform → Sector Perform | Get Alert |
| 01/16/2024 | Buy Now | 15.27% | Baird | Peter Arment | → $505 | Downgrade | Outperform → Neutral | Get Alert |
| 12/15/2023 | Buy Now | 7.97% | Deutsche Bank | Scott Deuschle | $541 → $473 | Downgrade | Buy → Hold | Get Alert |
| 12/14/2023 | Buy Now | 2.72% | Wolfe Research | Myles Walton | → $450 | Downgrade | Peer Perform → Underperform | Get Alert |
| 10/31/2023 | Buy Now | -0.71% | JP Morgan | Seth Seifman | $430 → $435 | Maintains | Neutral | Get Alert |
| 10/11/2023 | Buy Now | 26.68% | UBS | Gavin Parsons | → $555 | Initiates | → Buy | Get Alert |
| 09/28/2023 | Buy Now | 14.59% | Deutsche Bank | Myles Walton | → $502 | Initiates | → Buy | Get Alert |
| 09/18/2023 | Buy Now | -0.71% | Wells Fargo | Sarah Akers | $485 → $435 | Maintains | Equal-Weight | Get Alert |
| 08/03/2023 | Buy Now | 14.13% | RBC Capital | Ken Herbert | → $500 | Reiterates | Outperform → Outperform | Get Alert |
| 07/31/2023 | Buy Now | 10.71% | Wells Fargo | Sarah Akers | $448 → $485 | Maintains | Equal-Weight | Get Alert |
| 07/28/2023 | Buy Now | 40.38% | B of A Securities | Ronald Epstein | $655 → $615 | Maintains | Buy | Get Alert |
| 07/28/2023 | Buy Now | 10.71% | Citigroup | Jason Gursky | $502 → $485 | Maintains | Neutral | Get Alert |
| 05/11/2023 | Buy Now | 2.72% | Barclays | David Strauss | $580 → $450 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 04/28/2023 | Buy Now | 14.59% | Citigroup | Jason Gursky | $488 → $502 | Maintains | Neutral | Get Alert |
| 04/28/2023 | Buy Now | 7.97% | Wells Fargo | Sarah Akers | $470 → $473 | Maintains | Equal-Weight | Get Alert |
| 02/06/2023 | Buy Now | 11.85% | Credit Suisse | Scott Deuschle | $500 → $490 | Maintains | Outperform | Get Alert |
| 01/31/2023 | Buy Now | 7.28% | Wells Fargo | Matthew Akers | $460 → $470 | Maintains | Equal-Weight | Get Alert |
| 01/27/2023 | Buy Now | 11.39% | Citigroup | Jason Gursky | $544 → $488 | Maintains | Neutral | Get Alert |
| 01/27/2023 | Buy Now | 37.18% | Morgan Stanley | Kristine Liwag | $626 → $601 | Maintains | Overweight | Get Alert |
| 01/27/2023 | Buy Now | -8.7% | JP Morgan | Seth Seifman | $465 → $400 | Maintains | Neutral | Get Alert |
| 01/27/2023 | Buy Now | — | Wolfe Research | Myles Walton | — | Downgrade | Outperform → Peer Perform | Get Alert |
| 01/27/2023 | Buy Now | 18.69% | RBC Capital | Ken Herbert | $550 → $520 | Maintains | Outperform | Get Alert |
| 01/27/2023 | Buy Now | 22.12% | Susquehanna | Charles Minervino | $615 → $535 | Maintains | Positive | Get Alert |
| 01/27/2023 | Buy Now | 14.13% | Credit Suisse | Scott Deuschle | $540 → $500 | Maintains | Outperform | Get Alert |
| 01/27/2023 | Buy Now | 9.11% | Cowen & Co. | Cai Rumohr | → $478 | Downgrade | Outperform → Market Perform | Get Alert |
| 01/18/2023 | Buy Now | 5% | Wells Fargo | Matthew Akers | $575 → $460 | Maintains | Equal-Weight | Get Alert |
| 01/17/2023 | Buy Now | 14.13% | Cowen & Co. | Cai Rumohr | $570 → $500 | Maintains | Outperform | Get Alert |
| 01/13/2023 | Buy Now | -14.4% | Goldman Sachs | Noah Poponak | $440 → $375 | Downgrade | Neutral → Sell | Get Alert |
| 01/12/2023 | Buy Now | 23.26% | Credit Suisse | Scott Deuschle | $575 → $540 | Maintains | Outperform | Get Alert |
| 12/15/2022 | Buy Now | 42.89% | Morgan Stanley | Kristine Liwag | $585 → $626 | Maintains | Overweight | Get Alert |
| 12/08/2022 | Buy Now | 24.17% | Citigroup | Jason Gursky | → $544 | Initiates | → Neutral | Get Alert |
| 11/10/2022 | Buy Now | 33.53% | Morgan Stanley | Kristine Liwag | $530 → $585 | Maintains | Overweight | Get Alert |
| 10/28/2022 | Buy Now | 31.25% | RBC Capital | Ken Herbert | $550 → $575 | Maintains | Outperform | Get Alert |
| 10/28/2022 | Buy Now | 31.25% | Wells Fargo | Matthew Akers | $516 → $575 | Maintains | Equal-Weight | Get Alert |
| 10/14/2022 | Buy Now | — | JP Morgan | Seth Seifman | — | Downgrade | Overweight → Neutral | Get Alert |
| 10/12/2022 | Buy Now | 27.82% | Credit Suisse | Scott Deuschle | → $560 | Initiates | → Outperform | Get Alert |
| 10/11/2022 | Buy Now | 28.97% | Wolfe Research | Myles Walton | → $565 | Initiates | → Outperform | Get Alert |
| 09/28/2022 | Buy Now | 17.78% | Wells Fargo | Matthew Akers | $455 → $516 | Maintains | Equal-Weight | Get Alert |
| 08/31/2022 | Buy Now | 27.82% | Susquehanna | Charles Minervino | $530 → $560 | Maintains | Positive | Get Alert |
| 08/30/2022 | Buy Now | 25.54% | RBC Capital | Ken Herbert | → $550 | Initiates | → Outperform | Get Alert |
| 07/29/2022 | Buy Now | 20.98% | Susquehanna | Charles Minervino | $520 → $530 | Maintains | Positive | Get Alert |
| 07/29/2022 | Buy Now | 20.75% | Baird | Peter Arment | $488 → $529 | Upgrade | Neutral → Outperform | Get Alert |
| 07/12/2022 | Buy Now | 20.98% | Morgan Stanley | Kristine Liwag | $521 → $530 | Maintains | Overweight | Get Alert |
| 04/29/2022 | Buy Now | 10.02% | Wells Fargo | Matthew Akers | $472 → $482 | Maintains | Equal-Weight | Get Alert |
| 03/07/2022 | Buy Now | 7.74% | Wells Fargo | Matthew Akers | $390 → $472 | Maintains | Equal-Weight | Get Alert |
| 03/02/2022 | Buy Now | 18.92% | Morgan Stanley | Kristine Liwag | $428 → $521 | Maintains | Overweight | Get Alert |
| 01/28/2022 | Buy Now | -2.31% | Morgan Stanley | Kristine Liwag | $440 → $428 | Maintains | Overweight | Get Alert |
| 01/28/2022 | Buy Now | -0.25% | Susquehanna | Charles Minervino | $416 → $437 | Maintains | Positive | Get Alert |
| 01/11/2022 | Buy Now | — | Wolfe Research | Michael Maugeri | — | Downgrade | Outperform → Peer Perform | Get Alert |
| 01/10/2022 | Buy Now | — | Wells Fargo | Matthew Akers | — | Upgrade | Underweight → Equal-Weight | Get Alert |
| 01/05/2022 | Buy Now | -6.41% | Jefferies | Sheila Kahyaoglu | → $410 | Downgrade | Buy → Hold | Get Alert |
| 11/04/2021 | Buy Now | 0.43% | Morgan Stanley | Kristine Liwag | — | Maintains | Overweight | Get Alert |
| 10/29/2021 | Buy Now | — | Vertical Research | — | — | Downgrade | Buy → Hold | Get Alert |
| 09/23/2021 | Buy Now | -20.11% | Goldman Sachs | Noah Poponak | — | Upgrade | Sell → Neutral | Get Alert |
| 08/02/2021 | Buy Now | -23.53% | Wells Fargo | Matthew Akers | — | Maintains | Underweight | Get Alert |
FAQ
What is the target price for Northrop Grumman (NOC) stock?
The latest price target for Northrop Grumman (NYSE:NOC) was reported by BTIG on June 26, 2024. The analyst firm set a price target for $565.00 expecting NOC to rise to within 12 months (a possible 28.97% upside). 21 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Northrop Grumman (NOC)?
The latest analyst rating for Northrop Grumman (NYSE:NOC) was provided by BTIG, and Northrop Grumman initiated their buy rating.
When was the last upgrade for Northrop Grumman (NOC)?
The last upgrade for Northrop Grumman Corp happened on April 22, 2024 when Alembic Global raised their price target to N/A. Alembic Global previously had a neutral for Northrop Grumman Corp.
When was the last downgrade for Northrop Grumman (NOC)?
The last downgrade for Northrop Grumman Corp happened on June 21, 2024 when Bernstein changed their price target from N/A to $477 for Northrop Grumman Corp.
When is the next analyst rating going to be posted or updated for Northrop Grumman (NOC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Northrop Grumman, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Northrop Grumman was filed on June 26, 2024 so you should expect the next rating to be made available sometime around June 26, 2025.
Is the Analyst Rating Northrop Grumman (NOC) correct?
While ratings are subjective and will change, the latest Northrop Grumman (NOC) rating was a initiated with a price target of $0.00 to $565.00. The current price Northrop Grumman (NOC) is trading at is $438.10, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.